The Zacks Medical – Products industry faces challenges with slowing growth, adoption barriers, and funding hurdles. Emerging markets, like China, experience policy headwinds and margin pressures. Despite this, companies like NVST, BLFS, INFU, and MRMD are adapting to consumer preferences, witnessing share price increases, and carrying a favorable Zacks Rank.

Innovation in AI, medical mechatronics, and robotics is transforming the industry, with 3D printing reshaping precision and personalized healthcare. Increased demand for in-vitro diagnostics due to the COVID-19 pandemic and emerging markets’ growth potential are key trends driving the future of the medical products industry.

Envista Holdings, BioLife Solutions, InfuSystems Holdings, and MariMed are promising stocks in the medical products sector. These companies are poised for growth through operational improvements, strong demand recovery, and strategic partnerships. With a focus on innovation, expansion, and cost controls, they are positioned for success in the second half of 2025.

Read more at Nasdaq: 4 Medical Product Stocks to Watch From a Challenging Industry